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Abstract
We have developed a high-resolution genomic mapping technique that combines transposon-mediated insertional
mutagenesis with either capillary electrophoresis or massively parallel sequencing to identify functionally important regions
of the Venezuelan equine encephalitis virus (VEEV) genome. We initially used a capillary electrophoresis method to gain
insight into the role of the VEEV nonstructural protein 3 (nsP3) in viral replication. We identified several regions in nsP3 that
are intolerant to small (15 bp) insertions, and thus are presumably functionally important. We also identified nine separate
regions in nsP3 that will tolerate small insertions at low temperatures (30uC), but not at higher temperatures (37uC, and
40uC). Because we found this method to be extremely effective at identifying temperature sensitive (ts) mutations, but
limited by capillary electrophoresis capacity, we replaced the capillary electrophoresis with massively parallel sequencing
and used the improved method to generate a functional map of the entire VEEV genome. We identified several hundred
potential ts mutations throughout the genome and we validated several of the mutations in nsP2, nsP3, E3, E2, E1 and
capsid using single-cycle growth curve experiments with virus generated through reverse genetics. We further
demonstrated that two of the nsP3 ts mutants were attenuated for virulence in mice but could elicit protective immunity
against challenge with wild-type VEEV. The recombinant ts mutants will be valuable tools for further studies of VEEV
replication and virulence. Moreover, the method that we developed is applicable for generating such tools for any virus with
a robust reverse genetics system.
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Introduction
Venezuelan equine encephalitis virus (VEEV) is a New World
Alphavirus endemic to regions of South America. Normally
maintained in a rodent reservoir, VEEV can be transmitted by
mosquitoes to horses and humans where it can cause debilitating
and potentially fatal encephalitis. There are currently no vaccines
for VEE licensed for use in humans.
Alphaviruses contain an approximately 11–12 kb single-strand,
capped and polyadenylated positive-sense RNA genome. The 59
two-thirds of the genome encode the non-structural proteins; nsP1,
nsP2, nsP3, and nsP4, which are involved in genome replication
and transcription. The 39 one-third of the genome encodes the
structural proteins; capsid, E3, E2, 6K, and E1.
Much of what is known about the functions of Alphavirus non-
structural proteins has been elucidated through molecular and
classical genetics studies of two prototypical alphaviruses: Sindbis
virus (SINV), and Semliki Forest virus (SFV) (reviewed in
[1,2,3,4]). The non-structural proteins are initially translated as
two polyproteins, P123 and P1234. In SINV, and several other
alphaviruses including VEEV, the major non-structural polypro-
tein, P123, is produced by translation termination at an opal
codon at the end of nsP3. Occasional read-through of the opal
termination codon produces P1234. Cleavage of P1234 in cis by a
protease activity that resides in nsP2 generates a complex of P123
and nsP4 that can initiate minus-strand RNA synthesis. P123 is
cleaved into nsP1, nsP2, and nsP3, and these fully cleaved forms
generate a complex with cellular proteins, replicate the full-length
viral genome from minus-strand templates, and transcribe the
subgenomic RNA encoding the viral structural proteins.
The enzymatic activities and functional roles of nsP1, nsP2, and
nsP4 have been partially characterized. nsP1 has methyltransfer-
ase and guanylyltransferase activity [5,6,7,8,9], required for
capping RNA, and is necessary for synthesis of minus-strand
RNA [10]. nsP2 has multiple functions in viral replication. It has
RNA helicase activity [11] and NTPase activity [12,13], and the
C-terminus of nsP2 functions as a cysteine protease that cleaves
the non-structural polyproteins P123 and P1234 [14,15,16,17].
nsP2 has been found to enter cell nuclei and to be an inhibitor of
transcription of cellular messenger and ribosomal RNAs including
those involved in innate immune responses [18,19,20] nsP4 is the
RNA dependent RNA polymerase [21,22,23,24].
nsP3 is the least characterized of the Alphavirus nonstructural
proteins. Studies with SINV showed that nsP3 is essential for both
minus-strand and plus-strand synthesis, but the precise role that it
plays in these activities is unknown [25,26,27]. The protein
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highly conserved among alphaviruses and a hypervariable,
phosphorylated C-terminal domain. Macro domains (also called
X domains) are found in proteins from bacteria, archea, and
eukaryotes, as well as several viruses including alphaviruses,
coronaviruses, hepatitis E virus, and rubella virus [28,29,30,31].
They bind ADP-ribose and poly(ADP-ribose) and exhibit ADP-
ribose 10-phosphatase activity. The crystal structure of the VEEV
macrodomain was recently solved, revealing a conserved adeno-
sine binding pocket [32]. nsP3 is the only Alphavirus non-structural
protein that is phosphorylated [33], with most or all of the
phosphorylation on serine and threonine residues in the C-
terminus [34,35].
The studies that we report here were initiated to gain insight
into the function of VEEV nsP3. Toward this goal, we used
transposon mutagenesis, reverse genetics, and fragment analysis
by capillary electrophoresis to identify regions of the nsP3 gene
that are important for replication and that result in temperature
sensitive (ts) mutations. Although this work demonstrated the
utility of using insertional mutagenesis for identifying such
regions, the method was limited by the inherently low capacity
of fragment analysis by capillary electrophoresis. Consequently,
we developed a novel high-resolution functional mapping
technique that couples transposon insertional mutagenesis with
tag sequencing on a next-generation sequencing platform. We
used transposon mutagenesis to construct a cDNA library with
small DNA fragments randomly inserted throughout the VEEV
genome and then produced replication-competent virus
through reverse genetics. Comparing transposon insertion sites
in the resultant viruses to those in the starting library, we were
able to produce a functional map of the entire genome of
VEEV, and to identify several hundred potential ts mutations,
including those we originally identified with the capillary
electrophoresis method. We further validated the mutations in
cell culture assays of recombinant viruses generated through
reverse genetics and tested two of the nsP3 ts mutants in mice to
see if they could act as attenuated vaccines. These studies
provide both new information about the association of nsP3
gene regions with virulence, as well as a rapid and effective
method for identifying and creating new ts mutants for
replication studies.
Results
Construction and analysis of the nsP3 insertion library
We used a multistep transposon mutagenesis process to generate
a library of full-length VEEV clones with single insertions in nsP3
(Figure 1). Our final library consisted of 6.2610
6 full-length clones
of the VEEV genome with 15 bp insertions in nsP3 and had an
average complexity of approximately 200-fold coverage at every
nucleotide position. The 15 bp insertions consist of 10 bp derived
from a modified MuA transposon and 5 bp derived from
duplication of the transposition target site. The sequence derived
from the transposon contains a unique NotI restriction site that
allows for mapping the insert location in the VEEV genome. We
produced virus pools from the insert library by using standard
alphavirus reverse genetics, as depicted in Figure S1. Infectious
RNA was produced by in vitro transcription of the insert library,
and was transfected into BHK cells. The transfected BHK cells
were then incubated at 30uC to generate virus particles. Virus was
collected from the supernatant of the transfected cells and used to
infect fresh Vero cells at an MOI of 0.1. The low MOI infection
was intended to prevent trans-complementation caused by co-
infecting mutant viruses, which could confound our downstream
analyses. Infected cell cultures were incubated at either 30uC,
37uC, or 40uC to determine if there would be a temperature-
dependent difference in the functional maps of viruses produced at
these temperatures. RNA from our starting unselected pool, and
RNAs isolated from the 30uC, 37uC, and 40uC infection
supernatants were reverse transcribed and used as templates for
PCR amplification using primer combinations (Tables S1 and S2)
that generated amplicons of approximately 700 bp long with a
fluorescent FAM label on the 59 end, and a biotin tag on the 39
end. The amplicons were bound to streptavidin-coated magnetic
beads, and then digested with NotI to release any fragments
containing a NotI site derived from a transposon insertion. The
sizes of the released fragments were analyzed by capillary
electrophoresis on a Prism 3130XL Genetic Analyzer. We
included a FAM-labeled sequencing ladder of each amplicon to
accurately size fragments. To analyze results, we generated
electropherograms (Figure 2) in which the X-axis indicates the
size of the DNA fragment (the transposon insertion position), and
the Y-axis indicates the fluorescence intensity (the number of
transposon insertions at that position).
Examination of the electropherograms from the starting,
unselected library showed that it contained insertions after
approximately 30–40% of the nucleotides in nsP3. The observa-
tion that less than half of the nucleotide positions in nsP3 had an
insertion appeared to be due to a bias in MuA transposition, and
not inadequate coverage in the library, as a second, independent
insertion library gave a virtually identical insertion pattern (data
not shown).
Comparison of the library electropherograms to those derived
from viral genomes clearly revealed regions in nsP3 that would
and would not tolerate 15 bp insertions. As expected, most regions
of the highly conserved 59 end of nsP3 would not tolerate
insertions. Only one region in the 59 end, from nucleotides 4380 to
4395 (relative to the genome of the Trinidad donkey strain of
VEEV, Genbank accession number L01442), would tolerate
insertions at all temperatures (region 5, Figures 2A and B).
In contrast, the hypervariable 39 end of nsP3 tolerated
insertions at most positions. From nt 5023 (near the start of the
hypervariable region indicated in Figure 2C) to nt 5628, there
was no discernable difference in the vRNA electropherograms
compared to the unselected library RNA electropherogram.
However, we did find two regions in the 39 end, one from
Author Summary
Venezuelan equine encephalitis virus (VEEV) is a New
World Alphavirus that was first identified in Venezuela in
1938. VEEV normally circulates in rodent populations, but
during outbreaks it can jump to horses and humans where
it can cause debilitating and potentially fatal disease. There
are currently no vaccines or antiviral agents against VEEV
licensed for use in humans. In this study, we describe a
technique that we have developed that allows for the
rapid identification of viral mutants that can be useful for
studying the basic biology of viral replication. These
mutants can also be used to generate vaccines that
protect against infection with wild-type virus. We demon-
strate the utility of this technique by identifying over 200
mutations spread throughout VEEV genome that make the
virus unable to replicate efficiently at higher temperatures
(37uCo r4 0 uC.) Furthermore, we show that two of the
mutant viruses work as vaccines, and protect mice against
lethal infection with VEEV. This technique can be applied
to studying other viruses, and may allow for the rapid
identification of numerous vaccine candidates.
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5685 to 5702 (region 12) that were intolerant of insertions. We
were also able to detect 9 different sites in the 59 end of the nsP3
gene that would tolerate insertions at 30uC, but not at 37uCo r
40uC (summarized in Figure 2F). The degree of impairment of
viral replication varied from site to site. Some of the sites allowed
reduced replication at 37uC (i.e., detectable but reduced
electropherogram peaks relative to the 30uC peaks), while others
had no detectable replication at 37uC (e.g., compare Figure 2A
regions 1 and 2). At 40uC, most sites had no detectable
replication, but two had reduced replication (Figure 2B region
6 and Figure 2C region 9).
Functional analysis of the entire VEEV genome
For whole-genome analysis by massively parallel tag sequenc-
ing, it was necessary to develop a modified sequencing library
preparation protocol based on the Roche GS-FLX protocol such
that the libraries had the sequencing adapter (adapter A) ligated
onto the Not I sites that were present in the transposon insertions.
A schematic of the protocol used for preparing the sequencing
libraries is shown in Figure S2. Each prepared sequencing library
(30uC virus, 40uC virus, and unselected in vitro transcribed RNA)
was assessed on a single large region of a GS-FLX picotiter plate.
We obtained 92,260 sequencing reads from the 30uC library,
276,722 reads from the 40uC library, and 161,936 reads from the
unselected control RNA library. All analyses were normalized to
account for the different number of sequences obtained from each
sample. Sequencing reads arising from a transposon insertion
should have a characteristic sequence tag at the 59 end; thus, we
analyzed the bulk sequences obtained for the presence of the
correct tag, and those sequence reads lacking the tag were
excluded from further analysis.
We used the first 20 nucleotides of each sequencing read to
map the insert location on the VEEV genome. Because the
VEEV genome is relatively small (,1 1 . 5k b ) , 2 0b p w a s
sufficient to uniquely identify the insert locations. The total
number of insertions recorded at each nucleotide position in the
genome was tallied and used to build a histogram of insertion
frequencies across the entire genome (Data Set S1, and
Figure 3–5).
As expected, the histogram of the unselected RNA sample
showed insert locations spread throughout the entire genome
(Figure 3). In contrast, the histogram of insert locations isolated
from virus produced at 30uC showed several regions of the
genome that did not tolerate insertions. These regions were
presumably functionally important, and many of them mapped to
domains with functions known to be required for viral replication,
such as the nsP2 protease active site and substrate binding pocket
[36], and the nsP3/4 protease cleavage site.
Although the histograms of the 30uC virus and the 40uC virus
appeared quite similar, there were many locations within the
genome where we detected insertions at 30uC, but not at 40uC
(Figure 4), including those we identified in nsP3 using capillary
electrophoresis analysis of the insertional library (Figure S3). In
total, we found approximately 200 nucleotide positions within the
genome where the ratio of insertions detected at 30uC was greater
than or equal to 10 times the number of insertions detected at
40uC (Data Set S1).
Construction of ts mutants
Using the data obtained by comparing the histograms of insert
locations in the 30uC and 40uC vRNAs, we chose several
locations in which insertions would be predicted to cause a ts
phenotype. We constructed 10 mutants that contained 15 bp
insertions that would mimic the insertions generated by a
transposon insertion (Table 1.) We examined the single-cycle
replication kinetics of each of these mutants at 30uCa n d4 0 uC, as
compared to wild-type V3000. All of the mutants, with the
Figure 1. Generation of VEEV nsP3 insertion library. Entranceposon M1 – Kan
R was transposed into pBB300 and then processed to generate a
library of clones that contained 15 base-pair inserts in nsP3 (and short flanking regions in nsP2 and nsP4). (A) Diagram of plasmids pBB300 and
pBB305 and Entranceposon M1 – Kan
R. T7 - T7 promoter; nsP1-nsP4 – VEEV non-structural proteins; SG – VEEV subgenomic promoter; C, E3, E2, 6K, E1
– VEEV structural proteins. (B) Procedure for making full-length VEEV library with short insertions in nsP3.
doi:10.1371/journal.ppat.1001146.g001
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(Figure 6). Two of the mutants, ts7 and ts8, replicated to higher
titers than wild type at both 22 h and 46 h post infection.
However, at 40uC, all of the mutants had titers that were reduced
between 14- and 3300-fold relative to V3000 at 22 h post
infection (excluding mutant ts11 which had undetectable titers at
22 h). At 46 h post infection, most of the mutants still had titers
greater than 10-fold lower than wild-type V3000, but three
mutants (ts2, ts3-1, ts3-3) had titers similar to wild type. Mutant
ts11 had an extremely slow growth phenotype that made it
difficult to measure. Plaques were barely visible at 4 days post
infection, and took 7 to 10 days before accurate plaque counts
could be obtained. Plaques from the other ts mutants were
counted on day 3 post infection.
Figure 3. Frequency of insertion sites found in unselected RNA versus vRNA from virus produced at 30uC. The frequency of transposon
insertions at each nucleotide position in the VEEV genome was calculated from the GS-FLX sequencing data and normalized to account for
differences in the total number of sequencing reads obtained from each sample. For this histogram, the VEEV genome was divided into bins of 50
nucleotides from 59 to 39, and the total number of insertions in each bin was calculated. Insertion frequencies in unselected RNA are shown on top in
blue, and vRNA isolated from virus produced at 30uC is shown in red. The approximate location in the genome is indicated between the two datasets.
Gray bars indicate some of the regions intolerant to insertions at 30uC.
doi:10.1371/journal.ppat.1001146.g003
Figure 2. Functional mapping by capillary electrophoresis. Electropherogram data from five different amplicons spanning nsP3 are shown in
panels A-E and summarized in panel F. The X axis is the DNA fragment size, and the Y-axis is relative fluorescence (proportional to the number of
integrations at that site). From top to bottom in each panel, the electropherograms represent virus grown at 30uC, 37uC, and 40uC, and the
unselected control (lib). Regions of interest are shaded in grey. The approximate beginning and end of nsP3 are indicated by dotted lines in panels
(A) and (E), respectively. The end of the conserved region, and the beginning of the hypervariable region are indicated in panel (C). (A) Amplicon
BBU02+BBU017, nts 3932–4684; (B) Amplicon BBU04+BBU018, nts 4281–5059; (C) Amplicon BBU06+BBU019, nts 4613–5350; (D) Amplicon
BBU08+BBU020, nts 4961–5701; (E) Amplicon BBU010+BBU021, nts 5236–5803; (F) Compilation of nsP3 genetic mapping data. Regions intolerant to
15 bp insertions at all temperatures are shown in blue. Regions tolerant to insertions at 30uC, but intolerant at 37uCo r4 0 uC are indicated in green.
Regions tolerant to insertions at all temperatures are indicated in yellow. The locations of the macro domain, conserved region, and hypervariable
region are shown.
doi:10.1371/journal.ppat.1001146.g002
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Temperature-sensitive mutants have been used extensively to
elucidate replication and virulence properties of alphaviruses. To
demonstrate the utility of our functional mapping method for
identifying useful ts VEEV mutants, we further studied two nsP3 ts
mutants, ts3-1 and ts3-3 for replication, virulence, and immunoge-
nicity in mice. The insert locations in these two mutants are shown
in Figure 5. In addition to these two mutants, we constructed a
mutant with both the ts3-1 and ts3-3 insertions (double ts).
We infected groups of 10 Balb/c mice subcutaneously (s.c.) with
either a low dose (10 pfu) or a high dose (10
4 pfu) of ts3-1, ts3-3,
double ts, or wild-type V3000. A negative control group was
inoculated with PBS. All of the mice receiving the high-dose
V3000 had to be euthanized when moribund on day 6, while 8 of
10 mice receiving the low-dose V3000 inoculation were eutha-
nized when moribund by day 7. All of the mice that received either
high doses or low doses of any of the three ts mutants survived
without signs of disease, as did the negative control group.
As a verification that the ts mutants had actually infected the
mice, we assayed their sera for the presence of neutralizing
antibodies 28 days after infection. One mouse each in the low dose
V3000, ts3-1, and ts3-3 groups had no detectable neutralizing
antibodies, but all others did (Table 2 and Table S3).
Neutralizing antibodies are a correlate of protective immunity
to VEEV; thus we were interested in determining if the ts mutants
were able to serve as protective, live-attenuated vaccines.
Consequently, we challenged all of the surviving mice with 10
4
pfu of VEEV, strain Trinidad donkey, 28 days after their initial
infection with the ts mutants (Figure 7). All 10 of the negative
control mice that had received PBS in the initial inoculation were
euthanized when moribund on day 7 post challenge. One of the
two mice that had survived the low-dose V3000 inoculation, as
well as one mouse each in the low-dose ts3-1 and ts3-3 groups
were euthanized when moribund on day 7 post challenge. All of
the remaining mice survived for an additional 28 days post
challenge without displaying disease symptoms.
Discussion
The analysis of ts mutants has been used extensively to study
Alphavirus replication, and has helped to identify the activities and
interactions of many viral proteins [10,21,37,38,39,40,41,42,
43,44]. We originally planned to use functional mapping to gain
insight into the role(s) that nsP3 plays during viral replication
simply by mapping domains that would and would not tolerate
short insertions. However, we found that by performing functional
mapping on virus pools that had been produced at different
Figure 4. Frequency of insertion sites found in vRNAs of virus propagated at 30uCo r4 0 uC. Transposon insertion frequencies were
calculated for vRNAs isolated from 30uC and 40uC. Insertion frequencies for 50 nt bins are shown. 30uC frequencies are shown on top in blue, and
40uC frequencies are shown in red. Arrowheads indicate some of the regions in which more insertions were detected at 30uC than at 40uC.
doi:10.1371/journal.ppat.1001146.g004
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which could be used for more in depth studies of viral replication.
Our mapping of nsP3 identified several interesting features. Not
surprisingly, most of the conserved N-terminus of the protein was
intolerant to short insertions while most of the variable C-terminus
would tolerate insertions. Two regions in the C-terminus that
would not tolerate insertions spanned nucleotides 5628–5666 and
nucleotides 5684–5702. The latter region might be expected to be
intolerant to insertions, as that region encodes the extreme C
terminus of nsP3, including the cleavage site between nsP3 and
nsP4. Disruptions in this region could prevent cleavage of nsP3
from nsP4, which is an essential step in viral replication [45]. The
other site is more enigmatic. The region from 5628–5666 has no
obvious homology to known regions of importance, and will
require additional study to determine why insertions are not
tolerated. One recent study with SFV indicated that the extreme
C-terminus of nsP3 contains a degradation signal and a signal
important for its’ cellular localization [46]. The regions we have
identified here might play a similar role in VEEV replication.
In addition to these two intolerant regions, we also identified
nine separate regions in the 59 end of nsP3 that are ts for
insertions. Several of these regions mapped near ts regions
identified in SINV [21,25,26,47], but ts regions 1, 6, 9, and 10
were in regions that were not previously identified. Construction of
these ts mutants through reverse genetics will be required to more
fully characterize their roles in viral replication.
To generate a functional map of nsP3, we used fragment
analysis by capillary electrophoresis to generate functional maps in
a manner similar to one reported earlier [48,49]. While this
technique worked relatively well for analyzing short stretches of
DNA or RNA (i.e., up to 2 kb), the technique had limitations that
made it cumbersome for analysis of larger gene regions. For
example, we could only analyze individual amplicons of
approximately 600–800 bp due to the inherent loss of size
resolution in larger fragments. We also needed to include a
sequencing ladder in each electrophoretic analysis to obtain
accurate fragment size information. Because our mapping
fragments had short transposon-derived sequences appended to
the 39 end, fragment sizing with the sequencing ladder was not
exact. We theorized that functional mapping by using massively
parallel sequencing might overcome some of these issues. In
principle, the large number of sequencing reads obtained would
allow us to measure the relative frequencies of insertions at each
nucleotide position in the genome. Massively parallel sequencing
would also provide an exact sequence readout of the locations of
inserts and generate highly accurate maps. Lastly, mapping by
Figure 5. Location of nsP3 temperature sensitive mutants. The frequency of insertions at nt positions 4000–4250 at 30uC and 40uC is shown.
The location of the ts mutants that were generated for the mouse challenge study are indicated with arrows. Mutants used in the study had either a
single insertion at one of these locations (ts3-1 and ts3-3) or an insertion at both of these locations (double ts).
doi:10.1371/journal.ppat.1001146.g005
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or RNA to be examined in a single sequencing run.
For our studies, we used a Roche GS-FLX system, which was
adequate for mapping the approximately 11.5 kb VEEV genome
(,100 K–200 K reads per sample.) Viruses with larger genomes
could be mapped by using other sequencing platforms such as the
Illumina Genome Analyzer or Applied Biosystems SOLiD
sequencer. These platforms produce hundreds of millions of
sequencing reads, and would permit the analysis of a much larger
number of samples per sequencing run. Therefore, they are
probably the optimal systems for this type of analysis. Although the
length of sequencing reads obtained on these systems are shorter
than those obtained on the GS-FLX, the 35+ bp reads that they
generate should be enough to map insertion sites onto the
relatively simple genomes of viruses. In our analysis of VEEV, we
found that the first 20 nts of sequence was sufficient for mapping
each read back to the genome.
Functional mapping of the VEEV genome by using the
massively parallel sequencing method that we developed revealed
several hundred sites, spread throughout the genome in every
gene, where the number of insertions detected at 30uC was greater
than 10 times higher than the number of sequences detected at
40uC. All 10 sites that we chose for further analysis gave rise to a
virus with a ts phenotype, thus it is likely that most or all of the
other sites could also be reverse engineered to generate novel ts
mutant viruses that could be used for functional studies of VEEV
proteins. Many of the sites fell outside of the known functional
domains of VEEV proteins, such as the helicase and peptidase
domains of nsP2 and the RNA-dependent RNA polymerase
domain of nsP4, and may represent additional domains with
unknown functions in these proteins. Elucidating the mechanisms
of attenuation for these mutants will be important for identifying
additional functions required for viral replication.
In addition to providing new ts mutants for studying viral
replication, this method can also be used to map virulence
properties. For example, we demonstrated one use of functional
mapping data by constructing ts mutants that acted as attenuated
vaccines in a mouse model of lethal VEEV infection. None of the
mice vaccinated with these viruses showed any signs of disease,
and most were protected from challenge with wild-type VEEV. Of
the three mice that did succumb to challenge, all were in groups
that were inoculated with only 10 pfu of ts mutant virus; thus, it is
possible that these mice were not infected in the first place. This is
supported by the observation that one mouse in each group did
not develop neutralizing antibodies after infection with the ts
mutants. The utility of this technique for designing ts vaccines lies
not only in the ability to detect large numbers of ts mutants, but
also in the ability to multiplex those mutations to generate viruses
with a potentially more stable ts phenotype. In our study, we
demonstrated that we could combine two mutants in our double ts
mutant and still recover viable ts virus. It might be possible to
combine more than two mutations, with each additional mutation
reducing the reversion potential of the final attenuated virus.
Finally, although we only presented functional mapping data
relating to ts phenotypes, functional mapping of other phenotypes
is also possible using this technique. For example, comparison of
functional maps generated from RNA isolated from infected cells
to vRNAs isolated from the supernatant of infected cells might
identify mutants defective for particle formation. As an additional
example, we have performed preliminary functional mapping of
VEEV propagated in mosquito cells (C6/36) to identify insertions
that confer a species-specific replication phenotype, and have
identified several insertions in the VEEV genome that appear to
allow virus to replicate in Vero cells but not in C6/36 cells, and
vice versa. Similar studies could be performed to examine animal-,
organ-, or cell-specific replication characteristics of viruses. This
method should provide a powerful and new means to generate
tools for studying a myriad of characteristics of any virus with a
robust reverse genetics system.
Materials and Methods
Viruses and cell cultures
BHK and Vero cells were cultured in Eagle’s minimal essential
medium (EMEM) supplemented with 10% fetal bovine serum
(FBS). VEEV strain V3000 is derived from a molecular clone of
the wild-type Trinidad donkey strain of VEEV.
Generation of insertion libraries
For studies using only the nsP3 gene we used a VEEV reverse
genetics system derived from plasmid pVEE Replicon 1.0 [50],
which contains a T7 RNA promoter driving expression of the
VEEV 59 UTR and nsP1 through nsP4. pV3000 26S contains the
39 end of the VEEV genome, including the subgenomic promoter,
Table 1. Locations of temperature sensitive mutant insertions.
Mutant Insert gene Insert location Insert Amino Acid Sequence of Insert
ts2 nsP2 2969 TGCGGCCGCActggg 975G- CGRTG -N976
ts3 nsP2 3435 TGCGGCCGCAtccgc 1130P- LRPHP -R1131
ts5 E3 8432 TGCGGCCGCAcccat 290P- LRPHP -C291
ts7 E2 8921 TGCGGCCGCAcgtca 453V- MRPHV -T454
ts8 E2 9223 TGCGGCCGCAagtgc 554C- CGRKC -T555
ts10 E1 10474 TGCGGCCGCAatggg 971G- CGRNG -V972
ts11 E1 10905 TGCGGCCGCAtgcac 1115T- AAACT -L1116
ts17 Capsid 8153 TGCGGCCGCAccaag 197Q- VRPHQ -G198
ts3-1 nsP3 4069 TGCGGCCGCAgccac 1342T- AAAAT -A1343
ts3-3 nsP3 4216 TGCGGCCGCAgcagc 1391A- AAAAA -K1392
Genome locations of 15 bp inserts in temperature-sensitive mutants used in this study. The engineered insertions exactly mimic the expected insertions caused by
transposon insertions at these locations. Bases arising from target site duplication are in lower case. The resulting amino acid insertions are indicated. Positions of
flanking wild-type amino acids (in italics) are relative to either the non-structural or structural polyprotein.
doi:10.1371/journal.ppat.1001146.t001
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restriction digestions required for genetic analysis, NotI sites in both
pVEE Replicon 1.0 and pV3000 26S were changed to AscI sites by
digestion with NotI followed by ligation of a linker with the
sequence 59-GGCCGGCGCGCC-39. This change did not
interfere with virus production from the full-length genome. The
modified pVEE Replicon 1.0 was named pBB300, and the
modified pV3000 26S was named pBB305.
A MuA transposon, Entranceposon M1-Kan
R (1131 bp, part of
the Mutation Generation Kit from Finnzymes, Espoo, Finland),
was transposed into pBB300. Briefly, target DNA, Entranceposon
M1-Kan
R, and MuA transposase were combined in transposition
buffer, and the transposition was allowed to proceed for 1 h at
30uC. The transposase was then inactivated by heating to 75uC for
10 min. The transposition reaction was desalted on a Sephadex G-
50 spin column and transformed into DH5a E. coli. A primary
insertion library with full-length transposon insertions in pBB300
was isolated by plating the transformed cells on LB containing
ampicillin and kanamycin. The Mutation Generation Kit has been
optimized so that greater than 99% of the clones in the library will
contain a single transposon insertion. A fragment containing
transposon insertions in nsP3 (and small fragments of nsP2 and
nsP4) was isolated from the primary insertion library by digestion
with AvrII and BsiWI. This fragment was cloned into AvrII-BsiWI
cut pBB300, yielding a secondary library that only contained full-
length transposon insertions in nsP3. Digestion of the secondary
library with NotI, followed by intramolecular ligation, generated a
tertiary library consisting of clones with 15 bp inserts spread
throughout nsP3. Finally, the 26S ApaI-AscI fragment from
pBB305 was cloned into the ApaI-AscI cut tertiary library,
generating the final library of full-length VEEV genomes with
15 bp insertions in nsP3.
For studies using the entire VEEV genome, we constructed a
plasmid containing cDNA representing the full-length genome of
VEEV, strain Trinidad donkey (Genbank accession number
L01442), named pBB306. pBB306 was generated by cloning the
ApaI-AscI fragment from pBB305 (containing the VEEV structural
proteins) into ApaI-AscI cut pBB300. pBB306 has a T7 promoter
immediately upstream, and a unique AscIs i t ei m m e d i a t e l y
downstream of the VEEV genome. After linearization of the
plasmid with AscI, infectious viral RNAs (vRNA) were produced by
in vitro transcription with T7 RNA polymerase. Massively parallel
sequencing identified 10 nucleotide differences from the published
Trinidad donkey (accession #L01442) sequence as follows:
nucleotide (nt) 4151 A to G, nt 6044 T to C, nt 7208 T to C, nt
9073GtoA,nt9279AtoT,nt9397TtoC,nt9487CtoT,nt9531
A to G, nt 11386 C to T, and deletion of nt 11409 T in the 39 UTR.
Entranceposon M1-Kan
R was transposed into pBB306 and a
primary insertion library generated as described above. A
secondary library was prepared by digesting the primary library
with AscI and SbfI to release the VEEV genome from the plasmid
backbone. Size fractionation of this digest on an agarose gel
allowed isolation of VEEV genomes containing transposon
insertions, and removal of wild-type genomes lacking transposon
insertions. The transposon-containing genomes were re-cloned
into pBB306. This secondary library was digested with NotI,
followed by intramolecular ligation, to produce a tertiary library
consisting of clones with 15 bp inserts spread throughout the
VEEV genome. At least 60-fold coverage of the VEEV genome
was maintained in the library throughout the cloning process.
Recombinant virus production
Recombinant VEEV was produced essentially as described
previously [50,51]. Briefly, the nsP3 only or full genome insertion
Table 2. Serum neutralizing titers of groups inoculated with
VEEV ts mutants.
Group PRNT80
* Range
V3000, 10 PFU 226 ,20 to .5120
ts3-1, 10 PFU 2658 ,20 to .5120
ts3-1, 10000 PFU 4496 1920 to .5120
ts3-3, 10 PFU 2441 ,20 to .5120
ts3-3, 10000 PFU 3795 2168 to .5120
Double ts, 10 PFU 3286 1197 to .5120
Double ts, 10000 PFU 2887 698 to .5120
PBS ,20 All ,20
*80% plaque reduction neutralization titer, geometric mean.
doi:10.1371/journal.ppat.1001146.t002
Figure 6. Virus replication at 30uC and 40uC. Single-cycle growth
curves of viruses predicted to be ts based on functional mapping. Vero
cells were infected in duplicate at an MOI of 1, and incubated at either
30uC (A) or 40uC (B). Aliquots were removed at 0, 22 and 46 hr after
infection and virus was measured by plaque assay on Vero cells. Samples
in which virus was not detected are indicated with an asterisk (*).
doi:10.1371/journal.ppat.1001146.g006
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using T7 RNA polymerase (Ribomax, Promega, Madison, WI).
This RNA was introduced into BHK cells by electroporation and
the cells were then propagated in EMEM +10% FBS at 30uC until
noticeable cytopathic effects (CPE) were seen (approximately 2
days). Cell culture supernatant was centrifuged to remove cellular
debris, aliquoted, and frozen. The titer of the BHK-produced virus
was determined by plaque assay on Vero cells. In a second round
of infection, Vero cells were infected at a multiplicity of infection
(MOI) of 0.1 (low MOI) with BHK-produced virus. Cells were
incubated at 30uC, 37uCo r4 0 uC (for the nsP3 library), or 30uCo r
40uC (for the full genome library) and supernatant was collected
after extensive CPE was observed.
RNA isolation and RT-PCR
Virus from 50 ml of supernatant from the low MOI infections
was concentrated by ultracentrifugation. vRNA was isolated from
the viral pellets by Trizol-LS extraction (Invitrogen, Calsbad, CA).
In vitro-transcribed RNA that had not been used to produce virus
was used as the unselected pool, and was processed in parallel with
vRNAs. For capillary electrophoresis fragment analysis, RNAs
were reverse transcribed with random hexamer primers, and the
resulting cDNA was amplified by PCR in 100 ml reactions
(Platinum PCR Supermix High Fidelity, Invitrogen) using the
following combinations of primers (Table S2): BBU002 +
BBU017, BBU004 + BBU018, BBU006 + BBU019, BBU008 +
BBU020, BBU010 + BBU021. In all cases, the forward primer was
labeled with 6-FAM to facilitate detection and the reverse primer
was labeled with biotin for subsequent purification steps. The
amplicons were designed to overlap so that regions that would be
obscured near the ends of one amplicon could be analyzed in the
overlapping amplicons.
For massively parallel tag sequencing, RNA was processed with
the FirstChoice RLM-RACE kit (Applied Biosystems/Ambion,
Austin, TX) to add a 59-RACE adapter to the vRNAs, and reverse
transcription was performed using a mixture of VEEV-specific
primers and a 39-RACE adapter. The resulting cDNAs were
amplified by PCR, generating six overlapping amplicons (Table
S2). The amplicons spanned the entire genome, and were designed
to overlap so that primer binding sites that would be obscured at
the ends of each amplicon could be analyzed in the overlapping
amplicons. The primers used for PCR added AscI restriction sites
to both ends of each amplicon to facilitate sequencing library
preparation.
Capillary electrophoresis
Products from the RT-PCR reactions were processed with a
PCR purification kit (Edge Biosystems, Gaithersburg, MD), to
remove remaining primers, enzymes, and free nucleotides.
Samples were resuspended in restriction endonuclease buffer
(NEB, Beverly, MA) and bound to streptavidin-coated magnetic
beads (Invitrogen) for 1 h at 37uC. After binding, beads were
washed three times with 500 ml of restriction endonuclease buffer,
and were resuspended in 50 ml of restriction buffer containing 5
units of NotI restriction enzyme (NEB). Digests were incubated at
37uC for 1 h. After digestion, bead eluates were desalted on a
Figure 7. Kaplan-Meier analysis of mouse survival after challenge. Groups of 10 mice were innoculated with the VEEV ts strains and doses
indicated along the right hand side of the graph, or with PBS. 28 days post innoculation, mice were challenged with 10
4 pfu of wild-type VEEV strain
Trinidad donkey and monitored for an additional 28 days. Mice were euthanized when moribund. All mice surviving to day 14 survived to day 28,
when the study was terminated.
doi:10.1371/journal.ppat.1001146.g007
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resuspended in 10 ml of deionized formamide with a ROX-labeled
size standard (Geneflo 625, Chimerx, Milwaukee, WI). Samples
were denatured at 95uC for 2 min, and then loaded onto a Prism
3130XL Genetic Analyzer (Applied Biosystems, Foster City, CA)
for capillary electrophoresis. FAM-labeled dideoxy sequencing
ladders of each amplicon were run in parallel to allow for accurate
fragment sizing. Settings for the run were the same as the default
settings for fragment analysis on a 50 cm POP-7 array, except that
the run time was changed from 1800 s to 2200 s. Data from the
capillary electrophoresis runs were analyzed with Genemapper
software version 3.7 (Applied Biosystems) using the Local Southern
setting for peak sizing.
Library preparation for massively parallel sequencing
Amplicons that had been generated by RT-PCR were mixed
in an equimolar ratio to a final mass of 10 mg. The mixture was
digested with AscI to generate ligatable ends on each amplicon.
The AscI was heat inactivated, and the digest mixture was
purified over Sepharose to remove the small end fragments
generated by AscI digestion. The purified amplicons were
ethanol precipitated and resuspended in a 5 ml ligation mix
including T4 DNA ligase and T4 polynucleotide kinase, and the
ligation was incubated overnight at 16uC. The product of this
ligation was a collection of high molecular weight DNAs
(hmwDNA) with sizes greater than approximately 15 kb as
visualized on an ethidium bromide stained agarose gel. The
hmwDNAs were processed with a GS-FLX library preparation
kit (Roche) with a few modifications to the kit protocol. As per
the protocol, hmwDNAs were nebulized to generate small
fragments of double stranded DNA approximately 400–800 bp
in size. The ends of these fragments were polished with T4 DNA
polymerase and T4 polynucleotide kinase to produce blunt,
phosphorylated ends. In a departure from the kit protocol,
sequencing adapter ‘‘B’’ was ligated to both ends of the DNA
fragments. The fragments were then digested with Not I( w h i c h
cuts in the transposon insertions), and a modified sequencing
adapter ‘‘A’’ was ligated onto the exposed Not I ends. At this
point, we returned to the library preparation kit protocol to
finish preparing the sequencing libraries for each sample. The
final product for each was approximately 10 ng of sequencing
library. Sequencing out from the ‘‘A’’ adapter present on each
DNA fragment allowed us to identify the locations of the
transposon insertions in each sample.
GS-FLX sequencing and sequence analysis
The sequencing libraries were amplified onto sequencing beads
using the Roche emPCR kit II. This kit produces templates for
sequencing reactions starting from the ‘‘A’’ adapters. After
cleanup of the emPCR reactions, sequencing beads were loaded
onto a Picotiter plate and sequenced on the GS-FLX. Sequences
from one large region of a Picotiter plate were obtained for each
sample. The sequences obtained (between 92,000 and 276,000
per sample) were processed by a short PERL script to identify
those that contained a sequence tag indicative of a ‘‘true’’
sequence from a transposon insertion event. The sequence of
these tags was A(R)*CGGCCGCA. The first A was from the
modified ‘‘A’’ sequencing adapter. The (R)* came from a
multiplex identifier (MID) that was included at the 39 end of
the modified ‘‘A’’ adapter. The MID consisted of either four A or
four G residues. The CGGCCGC was the residual Not I site, and
the final A came from the 39 end of the transposon insertion.
Approximately 70% of the sequences from each sample
contained this sequence tag. The sequence of the first 20 bases
after the tag was BLASTed to the VEEV genome to identify the
location of the insertion [52]. To be included in the final analysis,
each BLAST result had to match the VEEV genome 100% over
the 20 base sequence. Approximately 95% of the tag-containing
sequences were successfully mapped to the VEEV genome using
these criteria. The insertion sites identified by BLAST were
tallied to build a histogram of insertion frequencies across the
VEEV genome.
Construction of temperature sensitive mutants
VEEV genomes carrying 15 bp insertions that mimicked a
transposon insertion were constructed by using a Quikchange XL
kit (Stratagene, La Jolla, CA.) Mutations were first constructed in
plasmids containing subgenomic fragments. The mutations were
confirmed by sequencing, and then transferred into a full-length
genomic plasmid (pBB306) by restriction digestion and cloning.
Mutant viruses were prepared from these full-length clones as
described above.
Growth curves
Vero cells plated in 6-well dishes were infected in duplicate with
wild-type and mutant viruses at an MOI of 1. After binding the
virus for 1 h at the appropriate temperature (30uCo r4 0 uC,) the
wells were washed once with PBS, and fresh medium was added. A
sample was taken immediately after adding the fresh medium, and
represented the 0 h time point. Infected cells were then cultured at
either 30uCo r4 0 uC, and additional samples were withdrawn from
the supernatant at 22 h and 46 h post infection. All samples were
frozen at 280uC prior to plaque assay.
Vaccination and challenge of mice
Groups of 10 6-to 8-week-old Balb/c mice were inoculated s.c.
with either 10 pfu or 10
4 pfu of ts mutant viruses. Control groups
received 10 or 10
4 pfu of V3000 or PBS. Mice were weighed and
examined daily for signs of disease, and euthanized when
moribund. Twenty-eight days after the initial inoculation with
the VEEV ts mutants, surviving mice were challenged s.c. with 10
4
pfu of VEEV, strain Trinidad donkey. Mice were weighed and
examined daily for signs of disease, and euthanized when
moribund.
Virus neutralization assays
Sera from vaccinated mice were serially diluted in Hank’s
Balanced Salt Solution (HBSS) containing 2% FBS. Serum
dilutions were incubated overnight at 4uC with 200 pfu of VEEV
Trinidad donkey. After incubation, the mixtures were assayed for
plaque formation on Vero cells. The 80% plaque reduction
neutralization titer (PRNT80) was calculated as the serum dilution
at which plaque formation was reduced by 80% relative to a
control that was incubated in the absence of serum.
Ethics statement
The mouse research protocol was approved by the US Army
Medical Research Institute of Infectious Disease Institutional
Animal Care and Use Committee in compliance with the Animal
Welfare Act and other federal statutes and regulations relating to
animals and experiments involving animals and adheres to
principles stated in The Guide for the Care and Use of Laboratory
Animals, National Research Council, 1996. The facility where the
research was conducted is fully accredited by the Association for
Assessment and Accreditation of Laboratory Animal Care,
International.
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Figure S1 Transposon mutagenesis and alphavirus reverse
genetics. A graphical representation of the protocol described in
the text. A plasmid containing the entire VEEV genome (pBB306)
was subjected to insertional mutagenesis by transposition of a
modified MuA transposon (Entranceposon M1-Kan
R shown in the
inset.) Removal of the bulk of the transposon by NotI digestion
followed by intramolecular ligation leaves a library of clones, each
containing a 15 bp insertion at an essentially random location in
the genome (blue Xs shown in the 15 bp insert library). Each
insertion contains a unique NotI site that can be used to map the
insert location. The library is transcribed in vitro to produce
infectious virus-like RNAs. These RNAs are transfected into cells,
yielding recombinant viruses after 24–48 hours.
Found at: doi:10.1371/journal.ppat.1001146.s001 (0.09 MB PDF)
Figure S2 Processing of vRNAs for massively parallel sequenc-
ing. A graphical representation of the protocol described in the
text. Viral genomic RNAs (vRNAs) are isolated from the
supernatant of infected cell cultures. RACE and RT-PCR are
used to generate amplicons that span the entire viral genome. The
amplicons are mixed in an equimolar ratio, and digested with AscI
(added by the primer during PCR) to generate 59 phosphorylated
ends. This mix is then ligated into a random jumble of high
molecular weight DNA (hmwDNA) to generate a starting material
for sequencing library preparation. The hmwDNA is nebulized
into fragments 400–800 bp in size, and the ends are polished to
generate blunt, 59 phosphorylated ends. Sequencing adapter ‘‘B’’
(shown in green) from the Roche library preparation kit is ligated
onto both ends of the polished DNAs. This mixture is then
digested with NotI to expose the ends of the transposon insertions,
and a biotinylated modified adapter ‘‘A’’ (shown in blue) is ligated
onto the exposed NotI ends. The mix is bound to streptavidin
coated magnetic beads and washed to remove any fragments
lacking the biotin tag. Templates for GS-FLX sequencing are
eluted from the magnetic beads as single stranded DNA.
Found at: doi:10.1371/journal.ppat.1001146.s002 (0.05 MB PDF)
Figure S3 Comparison of electropherogram data to results ob-
tained by sequencing. Electropherogram data (top), and sequencing
histogram (bottom) from approximately nt 4670 - nt 5220 in nsP3,
showing that similar results are obtained using both techniques.
Found at: doi:10.1371/journal.ppat.1001146.s003 (0.10 MB PDF)
Table S1 Oligonucleotides used in this study.
Found at: doi:10.1371/journal.ppat.1001146.s004 (0.03 MB
PDF)
Table S2 Amplicons used in this study.
Found at: doi:10.1371/journal.ppat.1001146.s005 (0.03 MB
PDF)
Table S3 Serum neutralizing titers for individual mice vacci-
nated with VEEV ts strains. 80% plaque reduction neutralization
titers (PRNT80) of individual animals after inoculation with
VEEV ts mutants. Titers registered as ,20 indicate that no
neutralization activity was seen at the lowest serum dilution (1:20).
Titers registered as .5120 indicate that plaque numbers were
reduced .80% (compared to a no-serum control) at the highest
dilution used in the assay (1:5120).
Found at: doi:10.1371/journal.ppat.1001146.s006 (0.03 MB PDF)
Data Set S1 Compiled sequencing data. Sequence reads
obtained from GS-FLX sequencing were processed as described
in the text. Columns F-H indicate the raw number of sequence
reads detected at each nucleotide position in the VEEV genome.
Columns I-K show the number of insertions per nucleotide
position normalized to 100000 reads per sample.
Found at: doi:10.1371/journal.ppat.1001146.s007 (2.36 MB XLS)
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